Limb-girdle muscular dystrophy: Difference between revisions
No edit summary |
|||
| Line 4: | Line 4: | ||
Caption = | | Caption = | | ||
DiseasesDB = 32189 | | DiseasesDB = 32189 | | ||
ICD10 = | | ICD10 = {{ICD10|G|71|0|g|70}} | | ||
ICD9 = {{ICD9|359.1}} | | ICD9 = {{ICD9|359.1}} | | ||
ICDO = | | ICDO = | | ||
| Line 13: | Line 13: | ||
MeshID = D049288 | | MeshID = D049288 | | ||
}} | }} | ||
'''Limb-girdle muscular dystrophy''' or '''Erb's muscular dystrophy''' is an [[autosomal]] class of [[muscular dystrophy]] that is similar but distinct from [[Duchenne muscular dystrophy]] and [[Becker's muscular dystrophy]]. Limb-girdle muscular dystrophy encompasses a large number of rare disorders. | |||
==Presentation== | |||
The term "limb-girdle" is used to describe these disorders because the muscles most severely affected are generally those of the hips and shoulders -- the limb girdle muscles. | The term "limb-girdle" is used to describe these disorders because the muscles most severely affected are generally those of the hips and shoulders -- the limb girdle muscles. | ||
Common symptoms of ''limb-girdle muscular dystrophy'' are [[muscle]] weakness, [[myoglobinuria]], [[ | Common symptoms of ''limb-girdle muscular dystrophy'' are [[muscle]] weakness, [[myoglobinuria]], [[pain]], [[myotonia]], [[cardiomyopathy]], elevated [[blood plasma|serum]] [[creatine kinase|CK]], and rippling muscles. | ||
The muscle weakness is generally symmetric, [[proximal]], and slowly progressive. | The muscle weakness is generally symmetric, [[proximal]], and slowly progressive. | ||
Generally | Generally pain is not present with LGMD, and mental function is not affected. | ||
LGMD can begin in childhood, adolescence, young adulthood or even later. The age of onset is usually between 10 and 30. Both genders are affected equally. When limb-girdle muscular dystrophy begins in childhood the progression appears to be faster and the disease more disabling. When the disorder begins in adolescence or adulthood the disease is generally not as severe and progresses more slowly. | LGMD can begin in childhood, adolescence, young adulthood or even later. The age of onset is usually between 10 and 30. Both genders are affected equally. When limb-girdle muscular dystrophy begins in childhood the progression appears to be faster and the disease more disabling. When the disorder begins in adolescence or adulthood the disease is generally not as severe and progresses more slowly. | ||
The [[distal]] muscles are affected late in LGMD, if at all. Over time (usually many years), the person with LGMD loses muscle bulk and strength. Eventually, he may need a power wheelchair or scooter, especially for long distances. | ==Prognosis== | ||
The [[distal]] muscles are affected late in LGMD, if at all. Over time (usually many years), the person with LGMD loses muscle bulk and strength. Eventually, s/he may need a power wheelchair or scooter, especially for long distances. | |||
While LGMD isn't a fatal disease, it may eventually weaken the [[heart]] and [[lung]] muscles, leading to illness or death due to secondary disorders. | While LGMD isn't a fatal disease, it may eventually weaken the [[heart]] and [[lung]] muscles, leading to illness or death due to secondary disorders. | ||
==Genetics== | |||
LGMD is typically an [[biological inheritance|inherited]] disorder, though it may be inherited as a [[dominant gene|dominant]], [[recessive gene|recessive]], or [[X-linked]] genetic defect. The result of the defect is that the muscles cannot properly form the [[protein]]s needed for normal muscle function. Several different proteins can be affected, and the specific protein that is absent or defective identifies the specific type of muscular dystrophy. | LGMD is typically an [[biological inheritance|inherited]] disorder, though it may be inherited as a [[dominant gene|dominant]], [[recessive gene|recessive]], or [[X-linked]] genetic defect. The result of the defect is that the muscles cannot properly form the [[protein]]s needed for normal muscle function. Several different proteins can be affected, and the specific protein that is absent or defective identifies the specific type of muscular dystrophy. | ||
Treatment for LGMD is primarily supportive. [[Exercise]] and [[physical therapy]] are advised to maintain as much muscle strength and joint flexibility as possible. | ==Treatment== | ||
Treatment for LGMD is primarily supportive. [[Exercise]] and [[physical therapy]] are advised to maintain as much muscle strength and joint flexibility as possible. [[Leg_brace|Calipers]] may be used to maintain mobility and quality of life. Careful attention to lung and heart health is also required. IVIg may increase strength in some forms and prevent progression in others, possibly through the prevention of fibrosis and inflammation without the secondary weakening caused by corticosteroids. | |||
==List of limb-girdle muscular dystrophies== | ==List of limb-girdle muscular dystrophies== | ||
Revision as of 14:30, 9 January 2009
| Limb-girdle muscular dystrophy | |
| ICD-10 | G71.0 |
|---|---|
| ICD-9 | 359.1 |
| DiseasesDB | 32189 |
| eMedicine | neuro/189 |
| MeSH | D049288 |
Limb-girdle muscular dystrophy or Erb's muscular dystrophy is an autosomal class of muscular dystrophy that is similar but distinct from Duchenne muscular dystrophy and Becker's muscular dystrophy. Limb-girdle muscular dystrophy encompasses a large number of rare disorders.
Presentation
The term "limb-girdle" is used to describe these disorders because the muscles most severely affected are generally those of the hips and shoulders -- the limb girdle muscles.
Common symptoms of limb-girdle muscular dystrophy are muscle weakness, myoglobinuria, pain, myotonia, cardiomyopathy, elevated serum CK, and rippling muscles.
The muscle weakness is generally symmetric, proximal, and slowly progressive.
Generally pain is not present with LGMD, and mental function is not affected.
LGMD can begin in childhood, adolescence, young adulthood or even later. The age of onset is usually between 10 and 30. Both genders are affected equally. When limb-girdle muscular dystrophy begins in childhood the progression appears to be faster and the disease more disabling. When the disorder begins in adolescence or adulthood the disease is generally not as severe and progresses more slowly.
Prognosis
The distal muscles are affected late in LGMD, if at all. Over time (usually many years), the person with LGMD loses muscle bulk and strength. Eventually, s/he may need a power wheelchair or scooter, especially for long distances.
While LGMD isn't a fatal disease, it may eventually weaken the heart and lung muscles, leading to illness or death due to secondary disorders.
Genetics
LGMD is typically an inherited disorder, though it may be inherited as a dominant, recessive, or X-linked genetic defect. The result of the defect is that the muscles cannot properly form the proteins needed for normal muscle function. Several different proteins can be affected, and the specific protein that is absent or defective identifies the specific type of muscular dystrophy.
Treatment
Treatment for LGMD is primarily supportive. Exercise and physical therapy are advised to maintain as much muscle strength and joint flexibility as possible. Calipers may be used to maintain mobility and quality of life. Careful attention to lung and heart health is also required. IVIg may increase strength in some forms and prevent progression in others, possibly through the prevention of fibrosis and inflammation without the secondary weakening caused by corticosteroids.
List of limb-girdle muscular dystrophies
The "LGMD1" family is autosomal dominant, and the "LGMD2" family is autosomal recessive.
| Name | OMIM | Location |
| LGMD1A | 159000 | TTID |
| LGMD1B | 159001 | LMNA |
| LGMD1C | 607801 | CAV3 |
| LGMD1D | 603511 | 7q |
| LGMD1E | 602067 | 6q23 |
| LGMD1F | 608423 | 7q32.1-q32.2 |
| LGMD1G | 609115 | 4q21 |
| LGMD2A | 253600 | CAPN3 |
| LGMD2B | 253601 | DYSF |
| LGMD2C | 253700 | SGCG |
| LGMD2D | 608099 | SGCA |
| LGMD2E | 604286 | SGCB |
| LGMD2F | 601287 | SGCD |
| LGMD2G | 601954 | TCAP |
| LGMD2H | 254110 | TRIM32 |
| LGMD2I | 607155 | FKRP |
| LGMD2J | 608807 | TTN |
| LGMD2K | 609308 | POMT1 |